Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit |
CRL's 2009 preclinical sales slide; but 2010 bookings upFalling preclinical demand may have dominated Charles River Laboratories’ (CRL) performance in 2009, but stagnant sales from its research models business also failed to impress. People on the move: pharma outsourcing jobsOutsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including a new management team at a NextPharma site and appointments at Quintiles. FDA: drug safety benefits of import inspection system easy to PredictThe US FDA says its new screening system will expedite the importation of genuine drugs and help inspectors focus their efforts on “high risk” products. MENA emerging as trial destination says ClinTec CEOImproving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar. |
News in brief
|
|
Berlin Packaging has agreed to acquire All-Pak, creating a combined company with annual revenues of $500m (€365m) and an expanded geographic, including Puerto Rico.
MDRNA’s liposomal drug delivery formulation, DiLA2, lost no potency when stored for 12 months in conditions ranging from -80ºC to 4ºC, helping to validate it for administration of UsiRNA.
Almost half of antimalarials in Senegal are substandard, according to a USP study which will be used by local regulators to focus efforts on high-risk products, brands and geographies.
|
|
Globalisation
More news |
|
|
Patient safety
More news |
|
|
Consolidation
More news |
|
|
Clinical evolution
More news |